LATEST HEALTH NEWS
In non-small-cell lung carcinoma (NSCLC) type of lung cancer, combination of alectinib and ixazomib can help overcome resistance to alectinib in patients with ALK gene rearrangement.
from Medindia Health News https://ift.tt/36ePyxF
No comments
Thanks for comment via will connect you within 24 hours.